137 related articles for article (PubMed ID: 17009337)
1. Epinephrine for the treatment of anaphylaxis: do all 40 mg sublingual epinephrine tablet formulations with similar in vitro characteristics have the same bioavailability?
Rawas-Qalaji MM; Simons FE; Simons KJ
Biopharm Drug Dispos; 2006 Dec; 27(9):427-35. PubMed ID: 17009337
[TBL] [Abstract][Full Text] [Related]
2. Sublingual epinephrine tablets versus intramuscular injection of epinephrine: dose equivalence for potential treatment of anaphylaxis.
Rawas-Qalaji MM; Simons FE; Simons KJ
J Allergy Clin Immunol; 2006 Feb; 117(2):398-403. PubMed ID: 16461140
[TBL] [Abstract][Full Text] [Related]
3. Is epinephrine administration by sublingual tablet feasible for the first-aid treatment of anaphylaxis? A proof-of-concept study.
Gu X; Simons KJ; Simons FE
Biopharm Drug Dispos; 2002 Jul; 23(5):213-6. PubMed ID: 12116053
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
5. Rapidly-disintegrating sublingual tablets of epinephrine: role of non-medicinal ingredients in formulation development.
Rachid O; Rawas-Qalaji M; Simons FE; Simons KJ
Eur J Pharm Biopharm; 2012 Nov; 82(3):598-604. PubMed ID: 22683694
[TBL] [Abstract][Full Text] [Related]
6. Fast-disintegrating sublingual epinephrine tablets: effect of tablet dimensions on tablet characteristics.
Rawas-Qalaji MM; Simons FE; Simons KJ
Drug Dev Ind Pharm; 2007 May; 33(5):523-30. PubMed ID: 17520443
[TBL] [Abstract][Full Text] [Related]
7. Fast-disintegrating sublingual tablets: effect of epinephrine load on tablet characteristics.
Rawas-Qalaji MM; Simons FE; Simons KJ
AAPS PharmSciTech; 2006 Apr; 7(2):E41. PubMed ID: 16796358
[TBL] [Abstract][Full Text] [Related]
8. Adrenaline (epinephrine) microcrystal sublingual tablet formulation: enhanced absorption in a preclinical model.
Rawas-Qalaji M; Rachid O; Mendez BA; Losada A; Simons FE; Simons KJ
J Pharm Pharmacol; 2015 Jan; 67(1):20-5. PubMed ID: 25256073
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
11. Relative bioavailability of different buprenorphine formulations under chronic dosing conditions.
Strain EC; Moody DE; Stoller KB; Walsh SL; Bigelow GE
Drug Alcohol Depend; 2004 Apr; 74(1):37-43. PubMed ID: 15072805
[TBL] [Abstract][Full Text] [Related]
12. Technological evaluation and equivalence assessment of lorazepam tablets in rabbits.
Ventura CA; Giannone I; Musumeci T; Pignatello R; Puglisi G
Pharmazie; 2007 Jul; 62(7):515-8. PubMed ID: 17718192
[TBL] [Abstract][Full Text] [Related]
13. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.
Henney HR; Shah J
Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289
[TBL] [Abstract][Full Text] [Related]
14. Absolute bioavailability of quinine formulations in Nigeria.
Babalola CP; Bolaji OO; Ogunbona FA; Ezeomah E
Afr J Med Med Sci; 2004 Sep; 33(3):185-9. PubMed ID: 15819461
[TBL] [Abstract][Full Text] [Related]
15. In Vivo Evaluation of Taste-Masked Fast-Disintegrating Sublingual Tablets of Epinephrine Microcrystals.
Rachid O; Simons KJ; Rawas-Qalaji M
AAPS PharmSciTech; 2018 Nov; 19(8):3886-3894. PubMed ID: 30324360
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers.
Boonleang J; Panrat K; Tantana C; Krittathanmakul S; Jintapakorn W
Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: an open-label, randomized, two-period crossover comparison in healthy Mexican volunteers.
Galan-Herrera JF; Poo JL; Rosales-Sanchez O; Fuentes-Fuentes E; Cariño L; Burke-Fraga V; Namur S; Parra MG
Clin Ther; 2009 Aug; 31(8):1796-803. PubMed ID: 19808138
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evaluation of a fast-disintegrating lyophilized dry emulsion tablet containing griseofulvin.
Ahmed IS; Aboul-Einien MH
Eur J Pharm Sci; 2007 Sep; 32(1):58-68. PubMed ID: 17628451
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.
Rhim SY; Park JH; Park YS; Lee MH; Kim DS; Shaw LM; Yang SC; Kang JS
Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104
[TBL] [Abstract][Full Text] [Related]
20. Development and optimization of a sublingual tablet formulation for physostigmine salicylate.
Bolourchian N; Hadidi N; Foroutan SM; Shafaghi B
Acta Pharm; 2009 Sep; 59(3):301-12. PubMed ID: 19819826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
